TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
299,453
|
245,047
|
286,360 |
Financial expenses |
77,807
|
39,418
|
45,606 |
Earnings before taxes |
-115,767
|
-63,729
|
-33,074 |
EBITDA |
15,041
|
12,553
|
64,946 |
Total assets |
1,317,569
|
1,252,358
|
1,202,062 |
Current assets |
297,509
|
433,935
|
402,083 |
Current liabilities |
236,080
|
172,122
|
161,170 |
Equity capital |
389,522
|
496,394
|
368,384 |
- share capital |
58,542
|
58,242
|
44,404 |
Employees (average) |
115
|
105
|
109 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
29.6%
|
39.6%
|
30.6% |
Turnover per employee |
2,604
|
2,334
|
2,627 |
Profit as a percentage of turnover |
-38.7%
|
-26.0%
|
-11.5% |
Return on assets (ROA) |
-2.9%
|
-1.9%
|
1.0% |
Current ratio |
126.0%
|
252.1%
|
249.5% |
Return on equity (ROE) |
-29.7%
|
-12.8%
|
-9.0% |
Change turnover |
53,144
|
-18,117
|
40,309 |
Change turnover % |
22%
|
-7%
|
16% |
Chg. No. of employees |
10
|
-4
|
30 |
Chg. No. of employees % |
10%
|
-4%
|
38% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.